BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 2578770)

  • 1. [Combined chemotherapy for head and neck cancer using cisplatin, methotrexate and continuous subcutaneous infusion of peplomycin].
    Kagami Y; Nishio M; Saitoh A; Doi Y; Asano K; Sakurai T; Murakami Y; Narimatsu N
    Gan To Kagaku Ryoho; 1985 Feb; 12(2):337-42. PubMed ID: 2578770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cisplatin, methotrexate and peplomycin in the treatment of esophageal carcinoma].
    Kagami Y; Sakurai T; Nishio M; Narimatsu N; Saitoh A; Koshiba R; Ikeda H
    Gan To Kagaku Ryoho; 1986 Dec; 13(12):3523-6. PubMed ID: 2431655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of squamous cell carcinoma of the head and neck with multi-drug chemotherapy and radiotherapy].
    Nishio M; Kagami Y; Narimatsu N; Asano K; Sanbe S; Somekawa Y
    Gan To Kagaku Ryoho; 1989 Sep; 16(9):3111-8. PubMed ID: 2476971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combination chemotherapy of cisplatin, vincristine and peplomycin for patients with head and neck carcinoma].
    Tsukuda M; Tamamushi N; Mochimatsu I; Nakagawa C; Furukawa M; Kubota A; Hiiragi K; Nishimoto Y; Mitarai K; Oishi K
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):486-90. PubMed ID: 2420278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Induction chemotherapy with cisplatin and peplomycin in squamous cell carcinoma of the head and neck].
    Takagi T; Sakai C; Oguro M; Omura K; Shimada H; Takemiya S; Kuwahara T
    Gan To Kagaku Ryoho; 1987 Feb; 14(2):543-6. PubMed ID: 2434031
    [No Abstract]   [Full Text] [Related]  

  • 6. Multidrug chemotherapy using bleomycin, methotrexate, and cisplatin alone or combined with radiotherapy in advanced head and neck cancer.
    Kuten A; Zidan J; Cohen Y; Robinson E
    Cancer Treat Rep; 1983 Jun; 67(6):573-4. PubMed ID: 6190559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combined chemotherapy with cisplatin in esophageal cancer].
    Fukui H; Ide H; Hanyu F; Yamada A; Murata Y; Okushima N
    Gan To Kagaku Ryoho; 1987 Oct; 14(10):2865-9. PubMed ID: 2444165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of paclitaxel, ifosfamide, and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
    Shin DM; Glisson BS; Khuri FR; Hong WK; Lippman SM
    Semin Oncol; 1998 Apr; 25(2 Suppl 4):40-4; discussion 45-8. PubMed ID: 9578061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical effects and toxicity of chemotherapy with cisplatin for head and neck cancer--the multi-institutional joint research in Tokai district].
    Tohnai I; Kawabe Y; Nakashima T; Yamagiwa M; Suzuki T; Mizuno A; Mineda H
    Nihon Gan Chiryo Gakkai Shi; 1990 Oct; 25(10):2567-78. PubMed ID: 1702133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cisplatin, peplomycin, mitomycin C, and vincristine combination chemotherapy of non-small cell carcinoma of the lung].
    Saito H; Nomura F; Kawatsu H; Sakai S; Kobayashi T; Shimokata K
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2715-8. PubMed ID: 6210062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination chemotherapy for metastatic or locally advanced genitourinary squamous cell carcinoma: a phase II study of methotrexate, cisplatin and bleomycin.
    Corral DA; Sella A; Pettaway CA; Amato RJ; Jones DM; Ellerhorst J
    J Urol; 1998 Nov; 160(5):1770-4. PubMed ID: 9783949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in paclitaxel-containing chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck.
    Shin DM; Glisson BS; Khuri FR; Ginsberg L; Lawhorn K; Hong WK; Lippman SM
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-33-S19-37. PubMed ID: 9427263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II trial of dose-dense paclitaxel, cisplatin, 5-fluorouracil, and leucovorin with filgrastim support in patients with squamous cell carcinoma of the head and neck.
    Hitt R; Jimeno A; Millán JM; Castellano D; Cortés-Funes H
    Cancer; 2004 Aug; 101(4):768-75. PubMed ID: 15305408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck.
    Okuno SH; Mailliard JA; Suman VJ; Edmonson JH; Creagan ET; Nair S; Levitt R; Kugler JW
    Cancer; 2002 Apr; 94(8):2224-31. PubMed ID: 12001121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of advanced squamous cell carcinoma of the head and neck with cisplatin, bleomycin, and methotrexate (PBM).
    Ervin TJ; Weichselbaum R; Miller D; Meshad M; Posner M; Fabian R
    Cancer Treat Rep; 1981; 65(9-10):787-91. PubMed ID: 6168371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisplatin, fluorouracil, and L-leucovorin induction chemotherapy for locally advanced head and neck cancer: the M.D. Anderson Cancer Center experience.
    Papadimitrakopoulou VA; Dimery IW; Lee JJ; Perez C; Hong WK; Lippman SM
    Cancer J Sci Am; 1997; 3(2):92-9. PubMed ID: 9099459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weekly cisplatin paclitaxel and continuous infusion fluorouracil in patients with recurrent and/or metastatic head and neck squamous cell carcinoma: a phase II study.
    Schena M; Barone C; Birocco N; Dongiovanni D; Numico G; Colantonio I; Bertetto O
    Cancer Chemother Pharmacol; 2005 Mar; 55(3):271-6. PubMed ID: 15592837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an intergroup trial of the Eastern Cooperative Oncology Group.
    Gibson MK; Li Y; Murphy B; Hussain MH; DeConti RC; Ensley J; Forastiere AA;
    J Clin Oncol; 2005 May; 23(15):3562-7. PubMed ID: 15908667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salvage chemotherapy with PEM and long-CF regimen in CDDP refractory advanced head and neck cancer.
    Kohno N; Ichikawa G; Shirasaka T; Inuyama Y; Kawaida M; Ohnuma T
    Gan To Kagaku Ryoho; 1995 Aug; 22 Suppl 3():209-14. PubMed ID: 7661582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic chemotherapy with cisplatin plus 5-FU (PF) for recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): efficacy and safety of a lower dose of PF (80/800) at a single institution in Japan.
    Kiyota N; Tahara M; Kadowaki S; Fuse N; Doi T; Minami H; Ohtsu A
    Jpn J Clin Oncol; 2009 Apr; 39(4):225-30. PubMed ID: 19211574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.